Cyanocobalamin

Vitamin, B-vitamin, Hematinic

Cyanocobalamin (vitamin B12)

Many OTC and Rx; Nascobal (intranasal); generic injection

Experience

👥 No personal reports yet

⚕ No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary

Classes

Vitamin, B-vitamin, Hematinic

Common uses

Vitamin B12 deficiency▲0▼, Pernicious anemia▲0▼, Post-bariatric / malabsorptive supplementation▲0▼, Vegetarian/vegan supplementation▲0▼

Pharmacy

Starting dose

Replacement: 1000 mcg IM daily for 1 week, then weekly for 4 weeks, then monthly; or 1000-2000 mcg PO daily (effective even in pernicious anemia via passive diffusion); intranasal 500 mcg weekly

Preparations

100, 250, 500, 1000, 5000 mcg tablets (OTC and Rx); 1000 mcg/mL injection; intranasal spray; sublingual

US FDA Max

No strict ceiling; water-soluble vitamin, low toxicity

Pharmacology

Routes

Oral, sublingual, intranasal, IM, SC, IV

Onset

Reticulocyte response at 3-5 days; neurologic recovery weeks to months (and may be incomplete if longstanding)

Duration

N/A (replacement)

Half-life

~6 days (plasma); hepatic stores last 3-5 years

Bioavailability

Oral ~1-3% via passive diffusion at high doses (independent of intrinsic factor); IM/SC ~100%

Pregnancy

Routinely supplemented in vegan pregnancies and pernicious anemia.^{[citation needed]}

Legal status

OTC (low/mid-dose oral) and Rx-only (injection, intranasal) in US

Purported mechanism

Cyanocobalamin is an inactive storage/synthetic form of vitamin B12 that is converted intracellularly to methylcobalamin (cofactor for methionine synthase, regenerating methionine and tetrahydrofolate) and adenosylcobalamin (cofactor for methylmalonyl-CoA mutase, fueling propionyl-CoA / TCA entry).▲0▼ Failure of either coenzyme produces the characteristic megaloblastic anemia (THF trap) and subacute combined degeneration of dorsal columns and corticospinal tracts. Pernicious anemia is treated with high-dose oral or parenteral B12 because the autoimmune intrinsic factor loss is bypassed by mass-action passive diffusion at supraphysiologic doses.